Literature DB >> 458151

Effect of glucan on natural killer (NK) cells: further comparison between NK cell and bone marrow effector cell activities.

E Lotzová, J U Gutterman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 458151

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  6 in total

1.  Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells.

Authors:  V Vetvicka; B P Thornton; G D Ross
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

Review 2.  Natural bone marrow graft rejection phenomenon in mice.

Authors:  E Lotzová
Journal:  Surv Immunol Res       Date:  1982

3.  Update on the immunomodulating activities of glucans.

Authors:  N R Di Luzio
Journal:  Springer Semin Immunopathol       Date:  1985

4.  Extracellular polysaccharides purified from Aureobasidium pullulans SM‑2001 (Polycan) inhibit dexamethasone‑induced muscle atrophy in mice.

Authors:  Jong-Min Lim; Young Joon Lee; Hyung-Rae Cho; Dong-Chan Park; Go-Woon Jung; Sae Kwang Ku; Jae-Suk Choi
Journal:  Int J Mol Med       Date:  2017-11-10       Impact factor: 4.101

5.  Anti-osteoporotic effects of mixed compositions of extracellular polymers isolated from Aureobasidium pullulans and Textoria morbifera in ovariectomized mice.

Authors:  Chang-Soo Cho; Hye-Seong Jeong; In-Young Kim; Go-Woon Jung; Bon-Hwa Ku; Dong-Chan Park; Seung-Bae Moon; Hyung-Rae Cho; Khawaja Muhammad Imran Bashir; Sae Kwang Ku; Jae-Suk Choi
Journal:  BMC Complement Altern Med       Date:  2018-11-06       Impact factor: 3.659

6.  Ingestion of Exopolymers from Aureobasidium pullulans Reduces the Duration of Cold and Flu Symptoms: A Randomized, Placebo-Controlled Intervention Study.

Authors:  Jong-Min Lim; Eunju Do; Dong-Chan Park; Go-Woon Jung; Hyung-Rae Cho; Seo-Young Lee; Jae Wook Shin; Kyung Min Baek; Jae-Suk Choi
Journal:  Evid Based Complement Alternat Med       Date:  2018-05-30       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.